ABSTRACT: Introduction: It is a challenge to find participants for Alzheimer’s disease (AD) prevention trials within a short period of time. The European Prevention of Alzheimer’s Dementia Registry (EPAD) aims to facilitate recruitment by preselecting subjects from ongoing cohort studies. This article introduces this novel approach. Methods: A virtual registry, with access to risk factors…
DetailsThe mathematical modelling of disease progression is an essential part of several projects of the Innovative Medicine Initiative (IMI), namely AETIONOMY, EPAD, RADAR-AD; and it is subject of an entire work package in the European H2020 project VirtualBrainCloud. The joint interest in mathematical modelling of disease progression prompted us to come together for a first…
DetailsThe first quarter of 2016 started with great intensity! We were busy working towards recruiting the very first research participant into our study and should reach this important milestone early next month. A serious engagement of the entire EPAD family was also needed for the mandatory scientific and financial progress report to the Innovative…
DetailsOn 3rd November, we presented the first analysis of the EPAD data at CTAD (Clinical Trials on Alzheimer’s Disease) in Boston, USA. This analysis was primarily illustrative as did not come from the first data wave officially to be released when we have full baseline data from our first 500 research participants (due early…
DetailsThis is a unique opportunity for a future clinical academic neuroradiologist to gain research training experience while working on the neuroimaging data in the European Prevention of Alzheimer’s Dementia, EPAD research programme. http://ep-ad.org You will be based in a world-leading Academic Neuroradiology Department (under Professor Joanna Wardlaw), partnering with the Centre for Dementia Prevention (CDP)…
DetailsOur project leader Professor Craig Ritchie (pictured) is the new Chair of the Scottish Dementia Research Consortium (SDRC). SDRC is a membership based organisation which aims to support the development and expansion of high quality, co-ordinated, collaborative dementia research throughout Scotland. On 29 November, Alzheimer Scotland published an article on its website entitled “Help shape…
DetailsIn October 2018, two articles about the EPAD project were published. On 29 October, the journal Dementia published an article entitled “Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes”. The article led by Sarah Gregory from the University of Edinburgh (UK) described how the PREVENT Dementia panel forms…
DetailsFrom 15-17 May 2019, the EPAD project hosted its annual General Assembly meeting in Geneva (Switzerland). We were delighted that the event brought together EPAD delegates to discuss progress, latest developments and future plans. In attendance were scientists, researchers, representatives from pharmaceutical companies, patient organisations, SMEs, EPAD study site members, other experts and research participants…
DetailsThis year, the European Prevention of Alzheimer’s Dementia (EPAD) general assembly meeting was held in Amsterdam, under the banner “How to assure sustainability”. It was hosted by VU University Medical Center (VUmc) Amsterdam and kindly sponsored by VUmc, Amgen, Novartis and Janssen. The meeting provided a chance to gather everyone from across many different…
DetailsOn 7 March, EPAD passes the mark of 1.500 research participants for its Longitudinal Cohort Study (LCS)! Congratulations to the Trial Delivery Center in Bristol, who recruited participant number 1500. The largest ever public-private partnership in Alzheimer’s disease research, EPAD combines knowledge and expertise from 39 organisations across multiple sectors from academia and industry, bringing…
Details
